Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

Leukemia

Volumn 21, Issue 2, 2007, Pages 207-214

  Evans, P A S ^a   Pott, Ch ^b   Groenen, P J T A ^c   Salles, G ^d   Davi, F ^e   Berger, F ^d   Garcia, J F ^f   van Krieken, J H J M ^c   Pals, S ^g   Kluin, Ph ^h   Schuuring, E ^h   Spaargaren, M ^g   Boone, E ⁱ   Gonzalez D ^j   Martinez, B ^f   Villuendas, R ^f   Gameiro, P ^k   Diss, T C ^l   Mills, K ^m   Morgan, G J ^a   Carter, G I ⁿ   Milner, B J ^o   Pearson, D ^p   Hummel, M ^q   Jung, W ^r   Ott, M ^s   Canioni, D ^t   Beldjord, K ^t   Bastard, C ^u   Delfau Larue, M H ^v   van Dongen, J J M ^w   Molina, T J ^x   Cabecadas J ^k   more..

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f Centro Nacional de Investigaciones Oncológicas   (Spain)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ Heilig Hart Ziekenhuis   (Belgium)

^j HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^k INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^l ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^m CARDIFF UNIVERSITY   (United Kingdom)

ⁿ NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^o UNIVERSITY OF ABERDEEN   (United Kingdom)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^r UNIVERSITY OF GÖTTINGEN   (Germany)

^s Georg August University of Goettingen ^*  (Germany)

^t HÔPITAL NECKER ENFANTS MALADES   (France)

^u CENTRE HENRI BECQUEREL   (France)

^v HENRI MONDOR HOSPITAL   (France)

^w ERASMUS MEDICAL CENTER   (Netherlands)

^x HÔTEL DIEU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLONAL VARIATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FOLLICULAR LYMPHOMA; GENE LOCUS; GENE REARRANGEMENT; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STANDARDIZATION;

EID: 33846483156     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404479     Document Type: Article

References (40)

1. Brisco MJ, Tan LW, Orsborn AM, Morley AA. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 1990; 75: 163-167.
2. McCarthy KP, Sloane JP, Wiedemann LM. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol 1990; 43: 429-432.
3. Diss TC, Peng H, Wotherspoon AC, Isaacson PG, Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 1993; 169: 291-295.
4. Hummel M, Tamaru J, Kalvelage B, Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994; 84: 403-407.
5. Deane M, Norton JD. Immunoglobulin gene 'fingerprinting': An approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br J Haematol 1991; 77: 274-281.
6. Aubin J, Davi F, Nguyen-Salomon F, Leboeuf D, Debert C, Taher M et al. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 1995; 9: 471-479.
7. Owen RG, Johnson RJ, Rawstron AC, Evans PA, Jack A, Smith GM et al. Assessment of IgH PCR strategies in multiple myeloma. J Clin Pathol 1996; 49: 672-675.
8. Dunn-Walters D, Thiede C, Alpen B, Spencer J. Somatic hypermutation and B-cell lymphoma. Philos Trans R Soc London B 2001; 356: 73-82.
9. Tumas-Brundage K, Manser T. The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J Exp Med 1997; 185: 239-250.
10. Fukita Y, Jacobs H, Rajewsky K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity 1998; 9: 105-114.
11. Lebecque SG, Gearhart PJ. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5′ boundary is near the promoter, and 3′ boundary is approximately 1 kb from V(D)J gene. J Exp Med 1990; 172: 1717-1727.
12. Gonzalez D, Garcia-Sanz R. Incomplete DJH rearrangements. Methods Mol Med 2005; 113: 165-173.
13. Szczepanski T, Willemse MJ, van Wering ER, van Weerden JF, Kamps WA, van Dongen JJ. Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome. Leukemia 2001; 15: 1415-1423.
14. Gonzalez D, Balanzategui A, Garcia-Sanz R, Gutierrez N, Seabra C, van Dongen JJM et al. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: Immunobiological characteristics and clinical implications. Leukemia 2003; 17: 1398-1403.
15. Gonzalez D, Gonzalez M, Alonso ME, Lopez-Perez R, Balanzategui A, Chillon MC et al. Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR. Leukemia 2003; 17: 1051-1057.
16. Diss TC, Liu HX, Du MQ, Isaacson PG. Improvements to B cell clonality analysis using PCR amplification of immunoglobulin light chain genes. Mol Pathol 2002; 55: 98-101.
17. van der Burg M, Tumkaya T, Boerma M, de Bruin-Versteeg S, Langerak AW, van Dongen JJ. Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood 2001; 97: 1001-1008.
18. van der Burg M, Barendregt BH, Szczepanski T, van Wering ER, Langerak AW, van Dongen JJ. Immunoglobulin light chain gene rearrangements display hierarchy in absence of selection for functionality in precursor-B-ALL. Leukemia 2002; 16: 1448-1453.
19. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257-2317.
20. Tumkaya T, van der Burg M, Garcia Sanz R, Gonzalez Diaz M, Langerak AW, San Miguel JF et al. Immunoglobulin lambda isotype gene rearrangements in B cell malignancies. Leukemia 2001; 15: 121-127.
21. Garcia-Sanz R, Lopez-Perez R, Langerak AW, Gonzalez D, Chillon MC, Balanzategui A et al. Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma. Haematologica 1999; 84: 328-335.
22. Kneba M, Eick S, Herbst H, Willigeroth S, Pott C, Bolz I et al. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res 1991; 51: 3243-3250.
23. Ngan BY, Nourse J, Cleary ML. Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 1989; 73: 1759-1762.
24. Pott C, Tiemann M, Linke B, Ott MM, von Hofen M, Bolz I et al. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas. Leukemia 1998; 12: 1630-1637.
25. Williams ME, Swerdlow SH, Meeker TC. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 1993; 7: 1437-1440.
26. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001.
27. Langerak AW, Molina TJ, Lavender FL, Pearson D, Flohr T, Sambade C et al. PCR-based clonality testing in tissue samples with reactive lymphoproliferationR: Usefulness and pitfalls: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2006, (in press).
28. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854.
29. Jolly CJ, Wagner SD, Rada C, Klix N, Milstein C, Neuberger MS. The targeting of somatic hypermutation. Semin Immunol 1996; 8: 159-168.
30. Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder P. Structure of the human immunoglobulin mu locus: Characterization of embryonic and rearranged J and D genes. Cell 1981; 27: 583-591.
31. Linke B, Bolz I, Pott C, Hiddemann W, Kneba M. Use of UITma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions. Leukemia 1995; 9: 2133-2137.
32. Derksen PW, Langerak AW, Kerkhof E, Wolvers-Tettero IL, Boor PP, Mulder AH et al. Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol 1999; 12: 794-805.
33. Szczepanski T, Beishuizen A, Pongers-Willemse MJ, Hahlen K, Van Wering ER, Wijkhuijs AJ et al. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: Alternative PCR targets for detection of minimal residual disease. Leukemia 1999; 13: 196-205.
34. Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 110-118.
35. van der Velden VH, Bruggemann M, Hoogeveen PG, de Bie M, Hart PG, Raff T et al. TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse. Leukemia 2004; 18: 1971-1980.
36. Bruggemann M, White H, Gaulard P, Garcia-Sanz R, Gameiro P, Oeschger S et al. Powerful strategy for PCR-based clonality assessment in T-cell malignancies: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2006, (accepted for publication).
37. 32-incorporation PCR for the detection of rearrangements at the TCR-gamma locus. Diagn Mol Pathol 1996; 5: 297-298.
38. Weiss LM, Warnke RA, Sklar J, Cleary ML. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987; 317: 1185-1189.
39. Jacobson JO, Wilkes BM, Kwaiatkowski DJ, Medeiros LJ, Aisenberg AC, Harris NL. bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Cancer 1993; 72: 231-236.
40. Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002; 99: 3806-3812.